Boccon-Gibod I - Search Results

1

Normal PAI-2 level in French FXII-HAE patients.

Marlu R, Deroux A, Du-Thanh A, Boccon-Gibod I, Launay D, Bouillet L. Marlu R, et al. J Allergy Clin Immunol. 2017 May;139(5):1719-1720. doi: 10.1016/j.jaci.2016.12.982. Epub 2017 Mar 16. J Allergy Clin Immunol. 2017. PMID: 28318558 No abstract available.

2

Disease expression in women with hereditary angioedema.

Bouillet L, Longhurst H, Boccon-Gibod I, Bork K, Bucher C, Bygum A, Caballero T, Drouet C, Farkas H, Massot C, Nielsen EW, Ponard D, Cicardi M. Bouillet L, et al. Am J Obstet Gynecol. 2008 Nov;199(5):484.e1-4. doi: 10.1016/j.ajog.2008.04.034. Epub 2008 Jun 13. Am J Obstet Gynecol. 2008. PMID: 18554570

3

Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacks.

Bouillet L, Boccon-Gibod I, Ponard D, Drouet C, Cesbron JY, Dumestre-Perard C, Monnier N, Lunardi J, Massot C, Gompel A. Bouillet L, et al. Ann Allergy Asthma Immunol. 2009 Nov;103(5):448. doi: 10.1016/S1081-1206(10)60369-9. Ann Allergy Asthma Immunol. 2009. PMID: 19927548 No abstract available.

4

Type III hereditary angio-oedema: clinical and biological features in a French cohort.

Vitrat-Hincky V, Gompel A, Dumestre-Perard C, Boccon-Gibod I, Drouet C, Cesbron JY, Lunardi J, Massot C, Bouillet L. Vitrat-Hincky V, et al. Allergy. 2010 Oct;65(10):1331-6. doi: 10.1111/j.1398-9995.2010.02368.x. Epub 2010 Apr 7. Allergy. 2010. PMID: 20384613

5

[Bradykinin mediated angioedema].

Bouillet L, Boccon-Gibod I, Massot C. Bouillet L, et al. Rev Med Interne. 2011 Apr;32(4):225-31. doi: 10.1016/j.revmed.2009.11.021. Epub 2010 Jun 9. Rev Med Interne. 2011. PMID: 20538389 French.

6

Efficacy of icatibant treatment in patients with hereditary angio-oedema type I resistant to treatment with C1 inhibitor concentrate.

Bouillet L, Boccon-Gibod I, Dumestre-Perard C, Cesbron JY, Massot C. Bouillet L, et al. Br J Dermatol. 2011 Jun;164(6):1406-7. doi: 10.1111/j.1365-2133.2011.10316.x. Br J Dermatol. 2011. PMID: 21410680 No abstract available.

7

Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group.

Cicardi M, Bork K, Caballero T, Craig T, Li HH, Longhurst H, Reshef A, Zuraw B; HAWK (Hereditary Angioedema International Working Group). Cicardi M, et al. Allergy. 2012 Feb;67(2):147-57. doi: 10.1111/j.1398-9995.2011.02751.x. Epub 2011 Nov 30. Allergy. 2012. PMID: 22126399

8

Safety and efficacy of icatibant self-administration for acute hereditary angioedema.

Boccon-Gibod I, Bouillet L. Boccon-Gibod I, et al. Clin Exp Immunol. 2012 Jun;168(3):303-7. doi: 10.1111/j.1365-2249.2012.04574.x. Clin Exp Immunol. 2012. PMID: 22519593 Free PMC article.

9

Acquired C1-inhibitor deficiency: 7 patients treated with rituximab.

Branellec A, Bouillet L, Javaud N, Mekinian A, Boccon-Gibod I, Blanchard-Delaunay C, Oksenhendler E, Ollivier Y, Dunogué B, Amarger S, Ponard D, Drouet C, Mouthon L, Thomas M, Fain O; French National Reference Center for Angioedema (CREAK). Branellec A, et al. J Clin Immunol. 2012 Oct;32(5):936-41. doi: 10.1007/s10875-012-9691-2. Epub 2012 Apr 20. J Clin Immunol. 2012. PMID: 22526593

10

[Management of angiotensin-converting enzyme inhibitor-related angioedema: recommendations from the French National Center for Angioedema].

Nosbaum A, Bouillet L, Floccard B, Javaud N, Launay D, Boccon-Gibod I, Fain O; Groupe d’experts du CREAK; French National Center for Angioedema. Nosbaum A, et al. Rev Med Interne. 2013 Apr;34(4):209-13. doi: 10.1016/j.revmed.2012.12.017. Epub 2013 Feb 4. Rev Med Interne. 2013. PMID: 23380506 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

96 results

Search Page